Fauci says FDA will evaluate Merck’s new Covid therapy ‘as rapidly as they presumably can’
[ad_1] White Home chief medical advisor Dr. Anthony Fauci stated Friday that the Meals and Drug Administration will evaluate information on Merck and Ridgeback Biotherapeutics’ new Covid oral antiviral “as rapidly as they presumably can” in hopes of issuing an emergency use authorization. The businesses stated their antiviral therapy, molnupiravir, decreased the danger of hospitalization … Read more